World's Best Scientists 2026 revealed!
Award Badge
Immunology
Italy
2026

D-Index & Metrics

Immunology

D-Index
115
Citations
60773
World Ranking
390
National Ranking
8

Medicine

D-Index
116
Citations
61273
World Ranking
4298
National Ranking
131

Pier Luigi Meroni publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pier Luigi Meroni sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 761 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pier Luigi Meroni D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pier Luigi Meroni sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 115 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Italy Leader Award
  • 2025 - Research.com Immunology in Italy Leader Award

Overview

Pier Luigi Meroni is affiliated with the Istituto Auxologico Italiano in Italy. Their research primarily focuses on the field of Medicine, with significant contributions in Rheumatology, Immunology, Hematology, Infectious Diseases, and Genetics.

The main topics covered in their research include:

  • Systemic Lupus Erythematosus Research
  • Platelet Disorders and Treatments
  • COVID-19 Clinical Research Studies
  • Monoclonal and Polyclonal Antibodies Research
  • SARS-CoV-2 and COVID-19 Research
  • Renal Diseases and Glomerulopathies
  • Heparin-Induced Thrombocytopenia and Thrombosis

Frequent publication venues for their work include:

  • Annals of the Rheumatic Diseases
  • Autoimmunity Reviews
  • Frontiers in Immunology
  • Zenodo (CERN European Organization for Nuclear Research)
  • Journal of Autoimmunity

Notable recent papers authored or coauthored by Pier Luigi Meroni are:

  • "The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria," 2023, Arthritis & Rheumatology
  • "2023 ACR/EULAR antiphospholipid syndrome classification criteria," 2023, Annals of the Rheumatic Diseases
  • "Complement activation in patients with COVID-19: A novel therapeutic target," 2020, Journal of Allergy and Clinical Immunology
  • "Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome," 2020, Frontiers in Immunology
  • "Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases," 2020, Arthritis & Rheumatology

Frequent coauthors collaborating with Meroni include:

  • María Orietta Borghi
  • Maria Gerosa
  • Anǵela Tincani
  • Cecilia Beatrice Chighizola
  • Laura Andréoli

Best Publications

  • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

    S. Miyakis;M. D. Lockshin;T. Atsumi;D. W. Branch

  • 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Martin Aringer;Karen Costenbader;David Daikh;Ralph Brinks

  • Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

    Ricard Cervera;Jean Charles Piette;Josep Font;Munther A. Khamashta

  • EULAR recommendations for the management of antiphospholipid syndrome in adults

    Maria G Tektonidou;Laura Andreoli;Marteen Limper;Zahir Amoura

  • EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

    L. Andreoli;G. K. Bertsias;N. Agmon-Levin;S. Brown

  • Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

    R. Cervera;M. A. Khamashta;Y. Shoenfeld;M. T. Camps

  • Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases

    Yehuda Shoenfeld;Roberto Gerli;Andrea Doria;Eiji Matsuura

  • International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

    Nancy Agmon-Levin;Nancy Agmon-Levin;Jan Damoiseaux;Cornelis Kallenberg;Ulrich Sack

  • Pathogenesis of antiphospholipid syndrome: understanding the antibodies

    Pier Luigi Meroni;M. Orietta Borghi;Elena Raschi;Francesco Tedesco

  • Anti-inflammatory and immunosuppressive drugs and reproduction.

    Monika Østensen;Munther Khamashta;Michael Lockshin;Ann Parke

  • ANA screening: an old test with new recommendations

    Pier Luigi Meroni;Peter H Schur

  • Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women

    Antonio Brucato;Micol Frassi;Franco Franceschini;Rolando Cimaz

  • Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

    Peter Nash;Bruce Kirkham;Masato Okada;Proton Rahman

  • Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies

    Elena Raschi;Cinzia Testoni;Daniela Bosisio;Maria O. Borghi

  • Thrombus formation induced by antibodies to β2-glycoprotein I is complement-dependent and requires a priming factor

    Fabio Fischetti;Paolo Durigutto;Valentina Pellis;Alessandra Debeus

  • Cardiovascular disease in autoimmune rheumatic diseases

    Ivana Hollan;Pier Luigi Meroni;Joseph M. Ahearn;J.W. Cohen Tervaert

  • Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.

    Silvia S. Pierangeli;Pojen P. Chen;Elena Raschi;Silvia Scurati

  • Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.

    D. Preziati;L. La Rosa;G. Covini;R. Marcelli

  • Infectious origin of the antiphospholipid syndrome.

    Shoenfeld Y;Blank M;Cervera R;Font J

  • Differential Effects of Anti–β2-Glycoprotein I Antibodies on Endothelial Cells and on the Manifestations of Experimental Antiphospholipid Syndrome

    Jacob George;Miri Blank;Yair Levy;Pierluigi Meroni

  • Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis.

    Pietro Invernizzi;Mauro Podda;Pier Maria Battezzati;Andrea Crosignani

  • Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus.

    Patrick Gordon;Munther A Khamashta;Eric Rosenthal;John M Simpson

Frequent Co-Authors

Angela Tincani
Angela Tincani University of Brescia
Maria Orietta Borghi
Maria Orietta Borghi University of Milan
Wilma Barcellini
Wilma Barcellini Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Andrea Doria
Andrea Doria University of Padua
Yehuda Shoenfeld
Yehuda Shoenfeld Sheba Medical Center
Rolando Cimaz
Rolando Cimaz University of Milan
Ricard Cervera
Ricard Cervera University of Barcelona
Francesco Tedesco
Francesco Tedesco University of Trieste
Massimo Cugno
Massimo Cugno University of Milan
Guido Valesini
Guido Valesini Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in the healthcare side of Immunology, there are several online degree options that offer flexible learning paths. Programs like the easiest absn programs to get into provide a fast track for registered nurses to earn a Bachelor of Science in Nursing, a solid foundation for clinical immunology roles.

Entry-level nursing careers can start with practical nursing programs. Exploring the which lpn programs are easiest to get into helps students find accessible Licensed Practical Nurse pathways that lead to direct patient care, often intersecting with immunological health specialties.

Nurse practitioners play a critical role in diagnosing and managing immune-related disorders. The easiest np program options offer streamlined routes for nurses aiming to advance their careers and specialize in fields closely tied to immunology.

For mental health professionals interested in immune system impacts on psychiatric conditions, the top pmhnp programs deliver excellent clinical placement rates and comprehensive education in psychiatric mental health nursing, a growing area of immunology research.

Choosing the right program can accelerate your entry into these dynamic and rewarding healthcare careers connected to immunology.

Best Scientists Citing Pier Luigi Meroni

Trending Scientists

Recently Published Articles